Evidence map›Paper›PMID 38785446›Full record

ArticleJournal of clinical microbiology2024

Differential diagnosis of exanthematous viruses during the 2022 Mpox outbreak in Minas Gerais, Brazil.

Talita Émile Ribeiro Adelino, Sara Cândida Santos, Maurício Teixeira Lima, Alana Vitor Barbosa da Costa, Natália Rocha Guimarães, Luiz Marcelo Ribeiro Tomé, Marcos Vinícius Ferreira Silva, Amanda Matos Pereira, Kelly Cristina Magalhães Luiz, Ludmila Oliveira Lamounier and 7 more

Abstract read
In one paragraph

Article in Journal of clinical microbiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Talita Émile Ribeiro Adelino *Diretoria do Instituto Octávio Magalhães, Fundação Ezequiel Dias (Funed), Belo Horizonte, Minas Gerais, Brazil.ORCID 0000-0002-1471-0084
Sara Cândida Santos *Diretoria do Instituto Octávio Magalhães, Fundação Ezequiel Dias (Funed), Belo Horizonte, Minas Gerais, Brazil.
Maurício Teixeira Lima *Diretoria do Instituto Octávio Magalhães, Fundação Ezequiel Dias (Funed), Belo Horizonte, Minas Gerais, Brazil.ORCID 0000-0002-0830-3909
Alana Vitor Barbosa da CostaDiretoria do Instituto Octávio Magalhães, Fundação Ezequiel Dias (Funed), Belo Horizonte, Minas Gerais, Brazil.
Natália Rocha GuimarãesDiretoria do Instituto Octávio Magalhães, Fundação Ezequiel Dias (Funed), Belo Horizonte, Minas Gerais, Brazil.
Luiz Marcelo Ribeiro ToméDiretoria do Instituto Octávio Magalhães, Fundação Ezequiel Dias (Funed), Belo Horizonte, Minas Gerais, Brazil.
Marcos Vinícius Ferreira SilvaDiretoria do Instituto Octávio Magalhães, Fundação Ezequiel Dias (Funed), Belo Horizonte, Minas Gerais, Brazil.
Amanda Matos PereiraDiretoria do Instituto Octávio Magalhães, Fundação Ezequiel Dias (Funed), Belo Horizonte, Minas Gerais, Brazil.
Kelly Cristina Magalhães LuizDiretoria do Instituto Octávio Magalhães, Fundação Ezequiel Dias (Funed), Belo Horizonte, Minas Gerais, Brazil.
Ludmila Oliveira LamounierDiretoria do Instituto Octávio Magalhães, Fundação Ezequiel Dias (Funed), Belo Horizonte, Minas Gerais, Brazil.
Antônio Carlos Gomes JúniorDiretoria do Instituto Octávio Magalhães, Fundação Ezequiel Dias (Funed), Belo Horizonte, Minas Gerais, Brazil.
Adriana Aparecida RibeiroDiretoria do Instituto Octávio Magalhães, Fundação Ezequiel Dias (Funed), Belo Horizonte, Minas Gerais, Brazil.
Patrícia AlvarezLaboratório de Tecnologia Diagnóstica (LATED), Instituto de Tecnologia de Imunobiológicos (Bio-Manguinhos), Fundação Oswaldo Cruz (FIOCRUZ), Rio de Janeiro, Brazil.ORCID 0000-0003-0313-877X
Mônica Barcellos ArrudaLaboratório de Tecnologia Diagnóstica (LATED), Instituto de Tecnologia de Imunobiológicos (Bio-Manguinhos), Fundação Oswaldo Cruz (FIOCRUZ), Rio de Janeiro, Brazil.
Erna Geessien Kroon *Departamento de Microbiologia, Universidade Federal de Minas Gerais (UFMG), Belo Horizonte, Minas Gerais, Brazil.ORCID 0000-0003-2721-3826
Clara Guerra-Duarte *Diretoria de Pesquisa e Desenvolvimento, Fundação Ezequiel Dias (Funed), Belo Horizonte, Minas Gerais, Brazil.
Felipe Campos de Melo Iani *Diretoria do Instituto Octávio Magalhães, Fundação Ezequiel Dias (Funed), Belo Horizonte, Minas Gerais, Brazil.ORCID 0000-0002-3629-8529

Funding

Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) 406441/2022-7
6 · The paper itself

Abstract

The monkeypox virus (MPXV) outbreak, primarily endemic to Africa, has spread globally, with Brazil reporting the second-highest number of cases. The emergence of MPXV in non-endemic areas has raised concerns, particularly due to the co-circulation of other exanthematous viruses such as varicella-zoster virus (VZV) and molluscum contagiosum virus (MOCV). To perform an accurate differential diagnosis of MPXV during the ongoing outbreak in Minas Gerais, Brazil, a 5PLEX qPCR assay targeting orthopoxviruses (OPV), VZV, and MOCV was used to retrospectively analyze all clinical samples that tested negative for MPXV in the initial screening conducted at Funed. In summary, our study analyzed 1,175 clinical samples received from patients suspected of MPXV infection and found a positivity rate of 33.8% (397 samples) for MPXV using the non-variola qPCR assay. Testing the 778 MPXV-negative clinical samples using the 5PLEX qPCR assay revealed that 174 clinical samples (22.36%) tested positive for VZV. MOCV DNA was detected in 13 and other OPV in 3 clinical samples. The sequencing of randomly selected amplified clinical samples confirmed the initial molecular diagnosis. Analysis of patient profiles revealed a significant difference in the median age between groups testing positive for MPXV and VZV and a male predominance in MPXV cases. The geographic distribution of positive cases was concentrated in the most populous mesoregions of Minas Gerais state. This study highlights the challenges posed by emerging infectious diseases. It emphasizes the importance of epidemiological surveillance and accurate diagnosis in enabling timely responses for public health policies and appropriate medical care. IMPORTANCE: Brazil ranks second in the number of cases during the global monkeypox epidemic. The study, conducted in Minas Gerais, the second most populous state in Brazil with over 20 million inhabitants, utilized differential diagnostics, revealing a significant number of positive cases for other exanthematous viruses and emphasizing the need for accurate diagnoses. During the study, we were able to assess the co-circulation of other viruses alongside monkeypox, including varicella-zoster virus, molluscum contagiosum virus, and other orthopoxviruses. The significance of the research is underscored by the concentration of positive cases in populous areas, highlighting the challenges posed by emerging infectious diseases. This demographic context further amplifies the importance of the research in guiding public health policies and medical interventions, given the substantial population at risk. The study not only addresses a global concern but also holds critical implications for a state with such a large population and geographic expanse within Brazil. Overall, the study emphasizes the pivotal role of surveillance and precise diagnosis in guiding effective public health responses and ensuring appropriate medical interventions.

Indexed as

Disease OutbreaksAdolescentAdultAgedBrazilChildChild, PreschoolDiagnosis, DifferentialExanthemaFemaleHerpesvirus 3, HumanHumansInfantMaleMiddle AgedMonkeypox virusdifferential diagnosismolluscum contagiosum virusmonkeypox virusMpoxOrthopoxvirusoutbreakvaricella-zoster virus

Identifiers

PMID38785446
PMCPMC11237812

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.